Welcome to LookChem.com Sign In|Join Free
  • or
PHT-ILE-OH, a derivative of 1,3,4,6,7,8-hexahydro-2H-pyrrolo[3,4-g]indazole, is a chemical compound that features an isoleucine residue and a hydroxyl group. It is known for its unique structure and properties, which make it a promising candidate in the field of organic synthesis and drug discovery.

29588-88-3

Post Buying Request

29588-88-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

29588-88-3 Usage

Uses

Used in Organic Synthesis:
PHT-ILE-OH is used as a building block for the synthesis of various organic molecules, leveraging its unique structure to create new compounds with potential applications in different industries.
Used in Drug Discovery:
PHT-ILE-OH is utilized in pharmaceutical research for its potential biological activities and pharmacological properties, contributing to the development of new drugs and therapeutic agents.
Used in Material Development:
Due to its distinctive properties, PHT-ILE-OH is employed in the development of new materials, where its chemical structure may offer novel functionalities and performance characteristics.
Further research and exploration of PHT-ILE-OH are essential to uncover additional applications and to enhance its role in the fields of science and technology.

Check Digit Verification of cas no

The CAS Registry Mumber 29588-88-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,5,8 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 29588-88:
(7*2)+(6*9)+(5*5)+(4*8)+(3*8)+(2*8)+(1*8)=173
173 % 10 = 3
So 29588-88-3 is a valid CAS Registry Number.

29588-88-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name PHT-ILE-OH

1.2 Other means of identification

Product number -
Other names PHTHALYL-L-ISOLEUCINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:29588-88-3 SDS

29588-88-3Synthetic route

phthalic anhydride
85-44-9

phthalic anhydride

L-isoleucine
73-32-5

L-isoleucine

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
at 135℃;100%
at 140℃; for 0.166667h;99%
With triethylamine Inert atmosphere;98%
benzyl (2S,3S)-3-methyl-2-phthalimido-pentanoate
42406-41-7

benzyl (2S,3S)-3-methyl-2-phthalimido-pentanoate

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol99%
L-isoleucine hydrochloride
17694-98-3

L-isoleucine hydrochloride

methyl 2-((succinimidooxyl)carbonyl)benzoate
438470-19-0

methyl 2-((succinimidooxyl)carbonyl)benzoate

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 20℃; for 4h;81%
L-isoleucine
73-32-5

L-isoleucine

N-ethoxycarbonylphthalimide
22509-74-6

N-ethoxycarbonylphthalimide

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
With sodium carbonate In water40%
Stage #1: L-isoleucine; N-ethoxycarbonylphthalimide With sodium carbonate In water at 20℃; for 3h;
Stage #2: With hydrogenchloride In water at 0℃; pH=1-2;
With sodium carbonate In water at 20℃; for 5h;
Monomethyl phthalate
4376-18-5

Monomethyl phthalate

diethyl-<β chloride ethyl>-amine

diethyl-<β chloride ethyl>-amine

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 98 percent / DCC / 1,2-dimethoxy-ethane / 6 h / 0 °C
2: 81 percent / aq. K2CO3 / acetonitrile / 4 h / 20 °C
View Scheme
Monomethyl phthalate
4376-18-5

Monomethyl phthalate

alkali

alkali

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) thionyl chloride, DMF, 3.) triethylamine / 1.) reflux, 1 h, 2.) benzene, 3.) THF, 0 deg C, 2 h
2: 99 percent / H2 / 10percent Pd/C / ethanol
View Scheme
Multi-step reaction with 3 steps
1: 1.) thionyl chloride, DMF, 3.) triethylamine / 1.) reflux, 1 h, 2.) benzene, 3.) THF, 0 deg C, 2 h
2: 88 percent / Bu4NBr, 5percent NaOH / CH2Cl2; H2O / 1.17 h
3: 99 percent / H2 / 10percent Pd/C / ethanol
View Scheme
benzyl (2S,3S)-N-<2-(methoxycarbonyl)-benzoyl>-2-amino-3-methyl-pentanoate
157919-58-9

benzyl (2S,3S)-N-<2-(methoxycarbonyl)-benzoyl>-2-amino-3-methyl-pentanoate

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 88 percent / Bu4NBr, 5percent NaOH / CH2Cl2; H2O / 1.17 h
2: 99 percent / H2 / 10percent Pd/C / ethanol
View Scheme
methanol
67-56-1

methanol

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(2S,3S)-N-phthaloylisoleucine methyl ester
137649-35-5

(2S,3S)-N-phthaloylisoleucine methyl ester

Conditions
ConditionsYield
With hydrogenchloride at 10℃; for 4h;99%
With hydrogenchloride at 10℃;98%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(2S,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanoyl chloride
126926-31-6

(2S,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanoyl chloride

Conditions
ConditionsYield
With thionyl chloride for 1h; Ambient temperature;94%
With thionyl chloride In dichloromethane for 5h; Heating;88%
With thionyl chloride In toluene Reflux; Schlenk technique;
rhodium(II) acetate dimer

rhodium(II) acetate dimer

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

ethyl acetate
141-78-6

ethyl acetate

tetrakis[N-phthaloyl-(S)-iso-leucinate]bis(ethyl acetate)

tetrakis[N-phthaloyl-(S)-iso-leucinate]bis(ethyl acetate)

Conditions
ConditionsYield
Stage #1: rhodium(II) acetate dimer; N-phthaloyl-L-isoleucine In chlorobenzene for 3h; Inert atmosphere; Reflux;
Stage #2: ethyl acetate In hexane Inert atmosphere;
83%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

1-(4-tert-butylbenzyl)piperazine
956-61-6

1-(4-tert-butylbenzyl)piperazine

2-((2S,3S)-1-(4-(4-(tert-butyl)benzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl) isoindoline-1,3-dione

2-((2S,3S)-1-(4-(4-(tert-butyl)benzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl) isoindoline-1,3-dione

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.25h;
Stage #2: With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h;
Stage #3: 1-(4-tert-butylbenzyl)piperazine In dichloromethane at 20℃; for 24h;
80%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

C16H30N2OSi

C16H30N2OSi

C30H43N3O4Si

C30H43N3O4Si

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;79%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

diphenyl diselenide
1666-13-3

diphenyl diselenide

2,2'-dipyridyl disulfide bis-N-oxide
3696-28-4

2,2'-dipyridyl disulfide bis-N-oxide

(1SR,2S)-2-methyl-1-phenylseleno-1-phthalimido-butane

(1SR,2S)-2-methyl-1-phenylseleno-1-phthalimido-butane

Conditions
ConditionsYield
With tributylphosphine In tetrahydrofuran at 16℃; for 0.0833333h; Irradiation;78%
2-aminoethylpyridine
42088-91-5

2-aminoethylpyridine

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

C21H23N3O3

C21H23N3O3

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;73%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

ethanol
64-17-5

ethanol

ethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanoate
1423187-78-3

ethyl 2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanoate

Conditions
ConditionsYield
With sulfuric acid at 60℃; for 4h;72.46%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

2-(pyridin-2-yl)isopropyl amine
52568-28-2

2-(pyridin-2-yl)isopropyl amine

C22H25N3O3

C22H25N3O3

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;71%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

1-(4-bromobenzyl)piperazine
91345-62-9

1-(4-bromobenzyl)piperazine

2-((2S,3S)-1-(4-(4-bromobenzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl)isoindoline-1,3-dione

2-((2S,3S)-1-(4-(4-bromobenzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.25h;
Stage #2: With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h;
Stage #3: 1-(4-bromobenzyl)piperazine In dichloromethane at 20℃; for 24h;
69%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

1-(4-fluorophenylmethyl)piperazine
70931-28-1

1-(4-fluorophenylmethyl)piperazine

2-((2S,3S)-1-(4-(4-fluorobenzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl)isoindoline-1,3-dione

2-((2S,3S)-1-(4-(4-fluorobenzyl)piperazin-1-yl)-3-methyl-1-oxopentan-2-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.25h;
Stage #2: With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h;
Stage #3: 1-(4-fluorophenylmethyl)piperazine In dichloromethane at 20℃; for 24h;
69%
4-(phenethyl)piperazine
5321-49-3

4-(phenethyl)piperazine

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

2-((2S,3S)-3-methyl-1-oxo-1-(4-phenethylpiperazin-1-yl)pentan-2-yl)isoindoline-1,3-dione

2-((2S,3S)-3-methyl-1-oxo-1-(4-phenethylpiperazin-1-yl)pentan-2-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.25h;
Stage #2: With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h;
Stage #3: 4-(phenethyl)piperazine In dichloromethane at 20℃; for 24h;
67%
(2-aminomethylpyridine)
3731-51-9

(2-aminomethylpyridine)

N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

C20H21N3O3

C20H21N3O3

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;60%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

1-(4-trifluoromethylbenzyl)piperazine
107890-32-4

1-(4-trifluoromethylbenzyl)piperazine

2-((2S,3S)-3-methyl-1-oxo-1-(4-(4-(trifluoromethyl)benzyl)piperazin-1-yl)pentan-2-yl)isoindoline-1,3-dione

2-((2S,3S)-3-methyl-1-oxo-1-(4-(4-(trifluoromethyl)benzyl)piperazin-1-yl)pentan-2-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 0℃; for 0.25h;
Stage #2: With benzotriazol-1-ol In dichloromethane at 0℃; for 0.25h;
Stage #3: 1-(4-trifluoromethylbenzyl)piperazine In dichloromethane at 20℃; for 24h;
59%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(2S,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanamide
329686-65-9

(2S,3S)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanamide

Conditions
ConditionsYield
With 1H-imidazole In tetrahydrofuran at 60℃; for 4h;56.39%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

(Z)-N'-(4-chlorobenzylidene)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide
1637438-74-4

(Z)-N'-(4-chlorobenzylidene)-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide

Conditions
ConditionsYield
In ethanol for 4h; Reflux;55.54%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

3,4-dichlorobenzaldehyde
6287-38-3

3,4-dichlorobenzaldehyde

C21H19Cl2N3O3

C21H19Cl2N3O3

Conditions
ConditionsYield
In ethanol for 4h; Reflux;50.02%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

(Z)-2-(1,3-dioxoisoindolin-2-yl)-N'-(4-methoxybenzylidene)-3-methylpentanehydrazide
1637437-24-1

(Z)-2-(1,3-dioxoisoindolin-2-yl)-N'-(4-methoxybenzylidene)-3-methylpentanehydrazide

Conditions
ConditionsYield
In ethanol for 4h; Reflux;48.75%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

benzaldehyde
100-52-7

benzaldehyde

(Z)-N'-benzylidene-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide

(Z)-N'-benzylidene-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide

Conditions
ConditionsYield
In ethanol for 4h; Reflux;42.84%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

hydrogen ethyl malonate
1071-46-1

hydrogen ethyl malonate

ethyl (5S)-5-methyl-3-oxo-4-phthalimidoheptanoate

ethyl (5S)-5-methyl-3-oxo-4-phthalimidoheptanoate

Conditions
ConditionsYield
Stage #1: N-phthaloyl-L-isoleucine With 1,1'-carbonyldiimidazole In tetrahydrofuran at 20℃; for 16h; Inert atmosphere;
Stage #2: hydrogen ethyl malonate With triethylamine; magnesium chloride In tetrahydrofuran at 0 - 20℃; for 4.5h; Inert atmosphere;
14%
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

isobutyl chloroformate
543-27-1

isobutyl chloroformate

C19H23NO6

C19H23NO6

Conditions
ConditionsYield
With 4-methyl-morpholine In tetrahydrofuran at -20℃; for 0.166667h;
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

Ethyl 3-sec-butyl-2,5-dioxo-2,3-dihydro-5H-pyrrolo<1,2-a>isoindole-1-carboxylate

Ethyl 3-sec-butyl-2,5-dioxo-2,3-dihydro-5H-pyrrolo<1,2-a>isoindole-1-carboxylate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 94 percent / SOCl2 / 1 h / Ambient temperature
2: 76 percent / tetrahydrofuran / 4 h / Heating
3: 0 h / 500 °C / 0 - 0.01 Torr
View Scheme
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(4S,5S)-4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-5-methyl-3-oxo-2-(triphenyl-λ5-phosphanylidene)-heptanoic acid ethyl ester
175913-71-0

(4S,5S)-4-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-5-methyl-3-oxo-2-(triphenyl-λ5-phosphanylidene)-heptanoic acid ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 94 percent / SOCl2 / 1 h / Ambient temperature
2: 76 percent / tetrahydrofuran / 4 h / Heating
View Scheme
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(2S,3S)-2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-methyl-pentanoic acid 2-thioxo-2H-pyridin-1-yl ester
157919-38-5

(2S,3S)-2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-methyl-pentanoic acid 2-thioxo-2H-pyridin-1-yl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NMM / tetrahydrofuran / 0.17 h / -20 °C
2: Et3N, DMAP / tetrahydrofuran / 0.5 h
View Scheme
N-phthaloyl-L-isoleucine
29588-88-3

N-phthaloyl-L-isoleucine

(1SR,2S)-1-deutero-2-methyl-1-phthalimido-butane

(1SR,2S)-1-deutero-2-methyl-1-phthalimido-butane

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NMM / tetrahydrofuran / 0.17 h / -20 °C
2: Et3N, DMAP / tetrahydrofuran / 0.5 h
3: 34 percent / tetrahydrofuran / 0.08 h / 16 °C / Irradiation
4: 79 percent / Bu3SnD, AIBN / benzene / 2 h / 80 °C
View Scheme

29588-88-3Downstream Products

29588-88-3Relevant academic research and scientific papers

Synthesis of new amides based on N-Phthaloyl-α-Amino Acids

Tukhtaev,Yusupov,Vinogradova

, p. 3049 - 3058 (2021/05/28)

N-phthaloyl derivatives of aliphatic α-amino acids were synthesized using phthalanhydride under standard conditions. The optimization reaction carried out by the thermal method to obtain the amides of these N-phthaloyl amino acids resulted in transimitted rather than amidation. The target amides of N-phthaloyl-α-amino acids were obtained by acylation of the amine with the corresponding acid chloroanhydrides in dichloromethane. These results were compared with the results of a similar acylation in a non-polar solvent (benzene). The dependence of the direction of the reaction on the duration of the acylation and the amount of amine used was established. The conditions for the formation of the corresponding N-phthaloyl-α-amino acid amides and asymmetric phthalic acid diamides were found. It is noteworthy that the formation of diamides is directly proportional to the equivalent amount of amine and the duration of the reaction, which makes it possible to purposefully control the synthesis in one reactor.

General Access to Modified α-Amino Acids by Bioinspired Stereoselective γ-C?H Bond Lactonization

Vicens, Laia,Bietti, Massimo,Costas, Miquel

supporting information, p. 4740 - 4746 (2020/12/25)

α-Amino acids represent a valuable class of natural products employed as building blocks in biological and chemical synthesis. Because of the limited number of natural amino acids available, and of their widespread application in proteomics, diagnosis, drug delivery and catalysis, there is an increasing demand for the development of procedures for the preparation of modified analogues. Herein, we show that the use of bioinspired manganese catalysts and H2O2 under mild conditions, provides access to modified α-amino acids via γ-C?H bond lactonization. The system can efficiently target 1°, 2° and 3° γ-C?H bonds of α-substituted and achiral α,α-disubstituted α-amino acids with outstanding site-selectivity, good to excellent diastereoselectivity and (where applicable) enantioselectivity. This methodology may be considered alternative to well-established organometallic procedures.

Chiral sensors for determining the absolute configurations of α-amino acid derivatives

Chen, Zhongxiang,Fan, Hongjun,Yang, Shiwei,Bian, Guangling,Song, Ling

, p. 6933 - 6939 (2018/10/02)

A simple strategy for configurational assignments of alpha-amino acids has been developed by comparison of the proton NMR chemical shift values of the alpha hydrogens of N-phthaloyl protected alpha-amino acids in the presence of (R)-CSA 1 and (S)-CSA 1, respectively. Highly resolved NMR spectra can be obtained directly on the mixed solution of the chiral solvating agents with N-phthaloyl protected alpha-amino acids in NMR tubes, giving well distinguishable proton signals without interference which dramatically improve the accuracy of assignment and hasten the assigning procedure. The strategy is widely applicable for varied natural and non-natural amino acids.

Chelation-Assisted Palladium-Catalyzed γ-Arylation of Aliphatic Carboxylic Acid Derivatives

Dey, Aniruddha,Pimparkar, Sandeep,Deb, Arghya,Guin, Srimanta,Maiti, Debabrata

supporting information, p. 1301 - 1307 (2017/04/18)

A palladium(II)-catalyzed protocol for the highly regioselective remote γ-C–H arylation of aliphatic carboxylic acid has been disclosed. The 8-aminoquinoline moiety as an intramolecular bidentate chelator was found to be suitable for this γ-C–H arylation. Various aryl iodides successfully produced the regioselectively mono-arylated products with negligible diarylation. Functional group tolerance and easy-to-handle reaction conditions make this method attractive. (Figure presented.).

Enantiomerically Pure [2.2]Paracyclophane-4-thiol: A Planar Chiral Sulfur-Based Building Block Readily Available by Resolution with an Amino Acid Chiral Auxiliary

Vincent, Adrien,Deschamps, Damien,Martzel, Thomas,Lohier, Jean-Fran?ois,Richards, Christopher J.,Gaumont, Annie-Claude,Perrio, Stéphane

, p. 3961 - 3966 (2016/05/24)

Acyl chloride of N-phthaloyl-(S)-isoleucine is an efficient chiral auxiliary for the resolution of (±)-[2.2]paracyclophane-4-thiol. A preparative protocol, based on the conversion into diastereoisomeric thiolesters and separation by two fractional crystallizations and column chromatography, was developed. Deprotection with LiAlH4 allowed isolation of the individual thiol enantiomers in good yield (~40%) and high enantiomeric purity (ee >93%). The absolute configurations were determined by comparison of the optical rotation value of the products with literature data and were confirmed by X-ray crystallography.

Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes

Leite, Ana Cristina Lima,Barbosa, Fabio Fernandes,Cardoso, Marcos Verissimo De Oliveira,Moreira, Diogo R. M.,Coelho, Lucas Cunha D.,Da Silva, Elany Barbosa,Filho, Gevanio Bezerra De Oliveira,De Souza, Valdenia Maria Oliveira,Pereira, Valeria Rego A.,Reis, Luiza De C.,Ferreira, Paulo Michel Pinheiro,Pessoa, Claudia,Wanderley, Almir Goncalves,Mota, Fernanda Virginia B.,Da Silva, Teresinha G.

, p. 1701 - 1708 (2014/05/06)

A series of phthalimide analogs were synthesized by derivatization of phthalic anhydride, a highly toxic substance, using a "one pot" condensation reaction to α-amino acids. All phthaloyl amino acid derivatives presented anti-oral inflammatory activity, but compounds 2e and 2g were found to possess the best activities comparable to thalidomide.Most of the compounds effectively suppressed nitric oxide production inmurine cells stimulatedwith lipopolysaccharide. N-phthaloyl amino acids did not exhibit any significant cytotoxicity in vitro when tested against tumor cells as well as a spleen cell culture of BALB/c mice. Compounds 2a, 2g, and 2h were able to inhibit TNF-α and IL-1β production by macrophages. At the same concentration, thalidomide did not exhibit significant inhibitory activity. Springer Science+Business Media 2013.

Unexpected stereoselective synthesis of (Z)-β-alkenyl substituted β-amino phosphonates through β,γ-dihydrogen shift reaction catalyzed by a copper(I) complex and iodine [Cu(MeCN)4]PF 6/I2

Cai, Yan,Lyu, Hairong,Yu, Chengbin,Miao, Zhiwei

supporting information, p. 596 - 602 (2014/05/20)

A series of dialkyl a-diazophosphonates has been prepared from natural amino acids. The diazo decomposition of these diazophosphonate compounds with tetrakis(acetonitrile)copper(I) hexafluorophosphate/iodine, [Cu(MeCN) 4]PF6/I2, as catalyst has been investigated. It was found that the diazo decomposition of dialkyl a-diazophosphonates gave a mixture of β,γ-dihydrogen shift and 1,2-hydride migration products and afforded β-alk- enyl-substituted β-amino phosphonates with the Z configuration. The mechanism of this novel diazo decomposition process was discussed.

Novel phthalimide derivatives with TNF-α and IL-1β expression inhibitory and apoptotic inducing properties

Coêlho, Lucas Cunha Duarte,De Oliveira Cardoso, Marcos Veríssimo,Moreira, Diogo Rodrigo Magalh?es,De Moraes Gomes, Paulo André Teixeira,Cavalcanti, Suellen Melo Tibúrcio,Oliveira, Arsenio Rodrigues,De Oliveira Filho, Gevanio Bezerra,Pessoa De Siqueira, Lucianna Rabelo,De Oliveira Barbosa, Miria,De Oliveira Borba, Elizabeth Fernanda,Da Silva, Teresinha Gon?alves,Kaskow, Belinda,Karimi, Mahdad,Abraham, Lawrence J.,Leite, Ana Cristina Lima

, p. 758 - 765 (2014/06/10)

Modulation of the immune system is an emerging concept in the control of tumor growth. Bearing in mind the pharmacological properties of thalidomide and its phthalimide derivatives, we describe here the structural design, synthesis and pharmacological evaluation of N-acylhydrazones derived from phthalimide. The ability of these N-acylhydrazones in inhibiting the secretion of TNF-α in stimulated cells as well as in inhibiting the transcription of the TNF-α gene was evaluated. We identified N-acylhydrazones 6b and 9c, which substantially impaired TNF-α secretion, expression and reduced IL-1β production similar to thalidomide or Revlimid. N-Acylhydrazone 9c was also able to induce apoptosis in Jurkat cells, however it does not have either antiproliferative properties or cytotoxicity for mouse splenocytes. Beyond that, we have assayed the ability of these compounds to induce cell death and a number of them are able to induce apoptosis.

Rhodium(II)-catalyzed intramolecular carbonyl ylide formation of α-diazo-β-ketoesters derived from N-phthaloyl-α-amino acids

Enssle, Marc,Buck, Stefan,Werz, Roland,Maas, Gerhard

, p. 149 - 171 (2013/09/24)

Starting from L-alanine, L-phenylalanine, L-leucine, L -norleucine, or L-isoleucine, 2-diazo-3-oxo-4-phthalimido-alkanoates 8 were prepared in three steps. Considerable racemization occurred at the stage of the 3-oxo-4-phthalimido-alkanoates 7. Dirhodium tetraacetate effectively catalyzed the intramolecular formation of carbonyl ylides 9, which in the absence of a trapping reagent underwent a [3+3] cycloaddition reaction to form the dimers 10. Carbonyl ylides 9 underwent [3+2] cycloaddition reactions with several electron-deficient alkenes and alkynes to give oxygen and nitrogen containing multicyclic systems 12-16. The keto group of the αoxy-β-ketoester moiety of cycloadducts 2 and 12 is easily hydrated to give the gem-diol. ARKAT-USA, Inc.

Diastereoselective synthesis of γ-phthalimido-β-hydroxy esters and n-protected 4-amino-1,3-diols starting from natural α-amino acids

Essersi, Amel,Touati, Ridha,Hassine, Bechir Ben

scheme or table, p. 69 - 72 (2010/08/05)

An efficient diastereoselective synthes.is of γ-phthalimido-β- hydroxy esters and N-protected 4-amino-1,3- diols, starting from natural amino acids is described. The key synthetic strategies involve diastereoselective reduction of γ-phthalimido-β-keto esters with NaBH4 as hydride reducing. The diastereoselective reduction has been found to be highly selective if carried out in methanol at -78°C. Furthermore, the resulting diastereomeric mixture of the reduced products was successfully and cleanly separated by column chromatography.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 29588-88-3